Connector Inversion Probe Technology for DNA Amplification
Author Information
Author(s): Akhras Michael S., Unemo Magnus, Thiyagarajan Sreedevi, Nyrén Pål, Davis Ronald W., Fire Andrew Z., Pourmand Nader
Primary Institution: Stanford University
Hypothesis
Can a novel one-primer multiplex amplification system improve pathogen diagnosis and antibiotic resistance screening?
Conclusion
The Connector Inversion Probe (CIPer) technology successfully enhances the detection of pathogens and antibiotic resistance mutations.
Supporting Evidence
- CIPer technology was validated for pathogen diagnostics and antibiotic resistance detection.
- The method successfully genotyped 1 pg of plasmid DNA in the presence of 200 ng of human genomic DNA.
- CIPer detected all eight plasmids in a mixture, outperforming conventional PCR methods.
Takeaway
This study created a new way to test for germs and their resistance to medicine using just one type of DNA probe, making it easier and faster.
Methodology
The study combined components of previous assays with a gap filling strategy to create a one-primer multiplex amplification system, tested on HPV and Neisseria gonorrhoeae.
Limitations
The study focused on lowplex systems amplifying shorter DNA stretches and may not be applicable for longer sequences without further optimization.
Participant Demographics
Included 31 DNA extracts from Neisseria gonorrhoeae strains.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website